Economic evaluation of the hepatitis C elimination strategy in Greece in the era of affordable direct-acting antivirals

doi:10.3748/wjg.v25.i11.1327

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 25, Issue 11

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7272)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-4) series.

Item

Count

PDF

503

WORD

241

HTML

4307

Figures (1-5)

250

Tables (1-4)

220

Sum=5521

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

767

Download

984

Sum=1751

Mar 21, 2019 (publication date) through Nov 20, 2024

Times Cited of This Article

Times Cited (16)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastroenterol. Mar 21, 2019; 25(11): 1327-1340
Published online Mar 21, 2019. doi: 10.3748/wjg.v25.i11.1327

Full Size Figure Download Figure

Figure 1 Projections of future chronic hepatitis C virus infection and complications under different treatment strategies. A: Total number of viremic cases; B: Cirrhosis; C: Decompensated cirrhosis; D: Hepatocellular carcinoma; E: Liver deaths. WHO: World Health Organization.

Citation: Gountas I, Sypsa V, Papatheodoridis G, Souliotis K, Athanasakis K, Razavi H, Hatzakis A. Economic evaluation of the hepatitis C elimination strategy in Greece in the era of affordable direct-acting antivirals. World J Gastroenterol 2019; 25(11): 1327-1340
URL: https://www.wjgnet.com/1007-9327/full/v25/i11/1327.htm
DOI: https://dx.doi.org/10.3748/wjg.v25.i11.1327